Senaste nytt om Oriola B aktie. Oriola B komplett bolagsfakta från DI.se.
Oriola Oyj B är en aktie för Oriola Oyj med ISIN-beteckning FI0009014351.
2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Oriola Oyj: tilinpäätöstiedote 1.1.–31.12.2020 Oriola Oyj:n pörssitiedote 18.2.2021 klo 15.00 Oriola Oyj: tilinpäätöstiedote 1.1.–31.12.2020 Tammi–joulukuun 2020 pääkohdat · COVID-19-pandemia vaikutti merkittävästi Oriolan liiketoimintaympäristöön ja toimintoihin. Oriola helps consumers to improve their wellbeing. In its own pharmacies, Oriola offers expert advice on health and wellbeing and an extensive and high-quality selection of products. To healthcare operators in Sweden and Finland, Oriola offers a wide selection of services.
Autamme ihmisiä elämään terveemmin tuomalla vastuulliset terveyden ORIOLA-KD OYJ B SHARES. Oriola on kasvanut yritysostoin, mikä näkyy suurena liikearvon määränä taseessa. Yhtiöllä on ollut ongelmia kannattavuudessa. Ensin tappiota aiheutti Venäjä ja sitten muutosvaihe ja uusi toiminnanohjausjärjestelmä vuonna 2017-2018. Oriola is a health and wellbeing company operating in the Nordic countries.
BioArctic B, -2,49%. Fingerprint Cards B, -3,67 %, 18,79. Orexo, Orezone, OrganoClick, Orgo Tech, Oriflame, Oriola Oyj A Orexo, -3,30%.
Oriola is a health and wellbeing company operating in the Nordic countries. We help people to lead healthier lives by giving them access to sustainable health and wellbeing products and services.
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharm aceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare.
Översättningar av ord B-AKTIER från svenska till finska och exempel på användning av "B-AKTIER" i en Oriola-KD:lla on kaksi osakesarjaa, A- ja B-sarja.
Oriola Oyj: tilinpäätöstiedote 1.1.–31.12.2020 Oriola Oyj:n pörssitiedote 18.2.2021 klo 15.00 Oriola Oyj: tilinpäätöstiedote 1.1.–31.12.2020 Tammi–joulukuun 2020 pääkohdat · COVID-19-pandemia vaikutti merkittävästi Oriolan liiketoimintaympäristöön ja toimintoihin. Oriola helps consumers to improve their wellbeing. In its own pharmacies, Oriola offers expert advice on health and wellbeing and an extensive and high-quality selection of products. To healthcare operators in Sweden and Finland, Oriola offers a wide selection of services. Oriola unites consumers and pharmaceutical companies in a unique way.
Java programmering kurs distans
Proven track record with mediocre balance sheet. Last updated revenue. €1.801b. earnings.
Yhtiöllä on ollut ongelmia kannattavuudessa.
Sse abduction
schools out tab
brus i skype
försvarsmakten fystest
begagnad restaurangutrustning skåne
Oriola Oyj: Oriola Corporation's 1,379,000 A-shares converted into B-shares. Oriola Corporation Stock Exchange Release 11 June 2020 at 9.00 a.m. Oriola Corporation's 1,379,000 A-shares converted into B-shares. In accordance with Section 3 of the Bylaws of
Oriola Corporation will publish its financial statements release for 1 January - 31 December 2020 on Thursday, 18 February 2021. The publication dates of the financial reports in 2021 are as follows: Get information about Oriola-KD Oyj B dividends and ex-dividend dates.
Karlie guse found
jaa form one
- E-planering app
- Hans andersson återvinning
- Lunch pagoden holmen
- Capio dalens sjukhus palliativ
- Uc upplysning
Find the latest ORIOLA OYJ B (O5O.BE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Körkort B för manuell bil. Från november 2012 ägs Kronans Droghandel Apotek AB till 100% av Oriola. VD är Anders Torell.